RENMICE Trademark

Trademark Overview


On Wednesday, October 20, 2021, a trademark application was filed for RENMICE with the United States Patent and Trademark Office. The USPTO has given the RENMICE trademark a serial number of 79975694. The federal status of this trademark filing is REGISTERED as of Tuesday, August 1, 2023. This trademark is owned by Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. The RENMICE trademark is filed in the Natural Agricultural Products and Computer & Software Services & Scientific Services categories with the following description:

Live trees; live plants; hamsters, live; live animals; poultry, live; live laboratory animals; live menagerie animals, namely, mice; plant seeds; fodder; litter for animals

Technological research, namely, pharmaceutical research; development of products for others; research and development of new products for others; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; biological research; Medical and scientific research, namely, conducting clinical trials for others; research and development of antibodies; development of pharmaceutical preparations and medicines; pharmaceutical development services; pharmaceutical research and development; pharmaceutical testing; packaging design; architectural design; computer programming; research in the field of artificial intelligence; computer programming in medical care; conversion of data or documents from physical to electronic media
renmice

General Information


Serial Number79975694
Word MarkRENMICE
Filing DateWednesday, October 20, 2021
Status700 - REGISTERED
Status DateTuesday, August 1, 2023
Registration Number7123569
Registration DateTuesday, August 1, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements


Pseudo MarkREN MICE
Goods and ServicesLive trees; live plants; hamsters, live; live animals; poultry, live; live laboratory animals; live menagerie animals, namely, mice; plant seeds; fodder; litter for animals
Goods and ServicesTechnological research, namely, pharmaceutical research; development of products for others; research and development of new products for others; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; biological research; Medical and scientific research, namely, conducting clinical trials for others; research and development of antibodies; development of pharmaceutical preparations and medicines; pharmaceutical development services; pharmaceutical research and development; pharmaceutical testing; packaging design; architectural design; computer programming; research in the field of artificial intelligence; computer programming in medical care; conversion of data or documents from physical to electronic media

Classification Information


International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateMonday, January 3, 2022
Primary Code031
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameBiocytogen Pharmaceuticals (Beijing) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Monday, December 18, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 2, 2023GENERIC MADRID TRANSACTION SENT TO IB
Thursday, November 2, 2023GENERIC MADRID TRANSACTION CREATED
Wednesday, November 1, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 1, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 1, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, June 11, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 26, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 10, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 7, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Saturday, April 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 28, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 28, 2023NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
Thursday, March 23, 2023DIVISIONAL PROCESSING COMPLETE
Wednesday, March 1, 2023DIVISIONAL REQUEST RECEIVED
Thursday, March 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 1, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 27, 2022REFUSAL PROCESSED BY IB
Saturday, September 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 3, 2022REFUSAL PROCESSED BY MPU
Monday, August 1, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, July 31, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 27, 2022ASSIGNED TO EXAMINER
Friday, January 7, 2022APPLICATION FILING RECEIPT MAILED
Monday, January 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 23, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB